Parkinson’s disease is a progressive condition of the nervous system that slowly changes the way the body moves. It develops when certain nerve cells deep in the brain, which produce a chemical messenger called dopamine, gradually stop working. Many people first notice a slight tremor, stiffness, or slowness, and they naturally wonder whether a simple blood test could confirm the cause. The honest answer is reassuring but nuanced: there is no routine blood test that diagnoses Parkinson’s disease, and a doctor’s clinical assessment remains the foundation of diagnosis. In this article you’ll learn what the condition is, how to recognize its early and later symptoms, how doctors reach a diagnosis, which lab tests help rule out other explanations, and how treatment can help you stay active.
What is Parkinson’s disease?
Parkinson’s disease is a long-term, progressive disorder of the brain and nervous system. It mainly affects movement, but it also involves many functions that have nothing to do with walking or reaching, such as sleep, mood, digestion, and sense of smell. Symptoms usually begin on one side of the body and spread slowly over years. Progression varies widely from person to person, and many people live active, fulfilling lives for a long time with the right care.
The role of dopamine
Deep in the brain sits a small region called the substantia nigra. Its cells make dopamine, a messenger that helps movements stay smooth and coordinated. In Parkinson’s disease, these dopamine-producing cells are gradually lost, and a protein called alpha-synuclein clumps together inside neurons to form deposits known as Lewy bodies. As dopamine levels fall, movement becomes slower and less controlled. Most symptoms only appear once a large share of these cells has already been affected, which is one reason the disease can be present for years before it is recognized.
Who develops it and when
Parkinson’s disease usually appears after the age of 60, although a smaller number of people develop young-onset Parkinson’s before 50. It is slightly more common in men than in women. Age is the strongest known risk factor, followed by family history and certain genetic variants. The condition is not contagious, and having one symptom, such as an occasional tremor, does not mean a person has it.
Early signs and symptoms of Parkinson’s disease
The symptoms of Parkinson’s disease fall into two broad groups: motor symptoms, which affect movement, and non-motor symptoms, which affect other body systems. Early signs are often subtle and easy to attribute to normal aging, stress, or fatigue. Recognizing them matters because starting care early can make a real difference to daily comfort and function.
Motor symptoms
Movement-related changes are the most recognizable features of the disease. They typically include:
- A resting tremor, often starting in one hand or fingers, that eases with movement.
- Bradykinesia, or slowness of movement, which can make everyday tasks feel effortful.
- Muscle stiffness and rigidity that may be uncomfortable and limit range of motion.
- Balance and posture problems that raise the risk of falls as the disease advances.
- Smaller handwriting, a softer voice, reduced arm swing, and less facial expression.
Non-motor symptoms
Non-motor symptoms can be just as important, and several of them may appear years before any tremor. Common examples include a reduced or lost sense of smell, constipation, acting out dreams during sleep (a condition called REM sleep behavior disorder), depression, anxiety, fatigue, and lightheadedness on standing. Because these signs are common in the general population, they are not proof of Parkinson’s on their own. Taken together and combined with motor changes, however, they help build the overall picture a neurologist looks for.
| Symptom group | Veelvoorkomende voorbeelden | When it often appears |
|---|---|---|
| Early motor | Slight resting tremor on one side, smaller handwriting, reduced arm swing | Often the first change people notice |
| Established motor | Slowness of movement, muscle stiffness, balance problems | Central to the clinical diagnosis |
| Non-motor (may precede) | Reduced sense of smell, constipation, acting out dreams in sleep | Can appear years before movement changes |
| Non-motor (ongoing) | Fatigue, mood changes, lightheadedness on standing, sleep problems | Affect quality of life throughout the disease |
Wanneer moet je een arts raadplegen?
It is worth booking an appointment with a doctor if you or someone close to you notices any of the following, especially when several appear together:
- A tremor at rest, particularly on one side of the body, that persists over weeks.
- Growing stiffness, slowness, or difficulty with tasks such as buttoning a shirt.
- Changes in handwriting, walking, balance, or facial expression.
- New constipation, loss of smell, or acting out dreams alongside movement changes.
A single symptom is rarely a cause for alarm, and many of these signs have ordinary, treatable explanations. A medical evaluation is simply the fastest way to understand what is going on.
What causes Parkinson’s disease?
The direct cause of the symptoms is the loss of dopamine-producing cells in the substantia nigra, together with the buildup of alpha-synuclein. Why this process starts is not fully understood, and in most people no single cause can be identified. Researchers believe the disease results from a mix of genetic susceptibility and environmental factors acting over many years.
Known risk factors include increasing age, a family history of the disease, and specific gene variants such as LRRK2, GBA, and SNCA. Long-term exposure to certain pesticides and industrial chemicals has also been linked to higher risk. Most cases, however, are sporadic, meaning they occur without a clear inherited pattern. It is also important to separate Parkinson’s disease from parkinsonism, a broader term for similar movement problems that can follow a stroke, certain medications, or other neurological conditions. Because the look-alikes can be treatable, doctors must separate it from other neurological conditions, and you can review our guide to multiple sclerosis.
Hoe wordt de ziekte van Parkinson vastgesteld?
Parkinson’s disease is diagnosed clinically. That means a doctor, usually a neurologist, makes the diagnosis based on your medical history, your symptoms, and a careful neurological examination rather than on a single laboratory result. Internationally recognized criteria focus on the presence of bradykinesia together with tremor or rigidity, along with supportive features such as a clear response to dopamine-based medication. Imaging such as a DaTscan can help distinguish Parkinson’s from other causes of tremor, and doctors sometimes track symptoms over several visits before confirming the diagnosis.
Why there is no simple blood test for Parkinson’s disease
Because the damage happens inside specific brain cells, no routine blood marker can currently confirm the disease on its own. There is no equivalent of a cholesterol panel or a blood sugar test that says “yes” or “no” for Parkinson’s. Newer specialized tests can detect the misfolded alpha-synuclein protein, but they generally rely on spinal fluid or skin samples and are performed in specialist settings, not through a standard blood draw at a routine checkup. Blood-based research is advancing quickly, yet for now the diagnosis rests on clinical expertise supported by selected tests.
How blood and lab tests help rule out look-alikes
Even though blood work cannot confirm Parkinson’s, it plays a valuable role by ruling out conditions that can imitate it. An underactive thyroid, for example, can mimic slowness and fatigue, which is why doctors often check schildklierstimulerend hormoon (TSH). A vitamin deficiency can cause overlapping neurological symptoms, so it also helps to read our full vitamin B12 guide. In younger patients, doctors also screen for Wilson disease, a treatable copper disorder, by measuring ceruloplasmin and may order a dedicated copper levels blood test. Broad panels such as a complete blood count and metabolic testing may also be used. To make sense of the numbers on any lab report, you can follow onze gids voor het begrijpen van je bloedonderzoekresultaten.
The alpha-synuclein seed amplification assay
One of the most important recent advances is the alpha-synuclein seed amplification assay, often shortened to SAA. In plain terms, this laboratory test takes a small amount of a person’s spinal fluid (and, increasingly, skin) and checks whether it contains the misfolded alpha-synuclein that is a hallmark of the disease. The test uses the protein’s own tendency to clump, multiplying tiny amounts until they can be measured. It is a genuine step forward for accurate, biology-based diagnosis, but it remains a specialized test ordered by neurologists, not a routine blood test you would get at a yearly physical.
Treatments and management of Parkinson’s disease
There is currently no cure for Parkinson’s disease, but treatment can control symptoms effectively, often for many years. Care is usually tailored to the individual and adjusted over time as needs change. The goal is to keep you moving, comfortable, and independent for as long as possible.
Medicijnen
Most treatment plans are built around restoring or mimicking dopamine. The main options include:
- Carbidopa-levodopa, the most effective medication, which the brain converts into dopamine.
- Dopamine agonists such as ropinirole, which act on the same receptors as dopamine.
- MAO-B inhibitors such as rasagiline, which slow the breakdown of dopamine in the brain.
- COMT inhibitors such as entacapone, which help levodopa last longer between doses.
Over time, the response to levodopa can become less even, producing so-called motor fluctuations where symptoms return before the next dose or movements become involuntary. A recent international evidence review confirmed that several medications and procedures can smooth out these fluctuations, giving doctors a range of tools to fine-tune treatment.
Procedures and supportive therapies
When medication alone is not enough, deep brain stimulation can help. In this procedure, surgeons place thin electrodes in specific brain regions to reduce tremor and involuntary movements; it manages symptoms but does not cure the disease. Alongside medical treatment, physical therapy, regular exercise, speech therapy, and attention to diet and mental health all play a major role. A multidisciplinary team approach tends to give the best results and helps people adapt as the condition evolves.
Every person’s experience of Parkinson’s disease is different, and the pace of change is usually slow. With modern medication, therapy, and support, many people continue to work, travel, and enjoy their hobbies for years after diagnosis. Building a care team early, staying physically active, and treating non-motor symptoms such as sleep and mood problems all help protect quality of life over the long term. Regular follow-up also lets doctors adjust treatment as needs change.
Recente wetenschappelijke ontwikkelingen
Research on Parkinson’s disease is moving fast, especially around earlier and more accurate diagnosis. The findings below are promising, but most are still tools for research or specialist care rather than everyday tests. Here is what they mean in plain language.
- A large 2023 study of more than 1,100 people tested the alpha-synuclein seed amplification assay on spinal fluid. It correctly identified about 88 out of every 100 people who had Parkinson’s disease and was negative in about 96 out of every 100 people who did not. Remarkably, it also flagged the disease process in some people before their movement symptoms began. What this means for you: a more confident, biology-based diagnosis may become possible, though the test is still specialized and is not a home or routine blood test.
- In 2024, a group of experts proposed defining Parkinson’s biologically, based on the presence of alpha-synuclein, rather than on symptoms alone. The authors stressed that this framework is for research only and is not yet meant for use in the clinic. What this means for you: it lays the groundwork for future trials and earlier treatment, but your diagnosis today still rests on a doctor’s assessment.
- Blood-based markers are being studied intensively. A 2024 review that pooled dozens of studies found that alpha-synuclein carried in tiny blood-borne vesicles differs between people with and without Parkinson’s. Separately, a large 2025 analysis of blood proteins hinted at changes years before diagnosis. What this means for you: a simple blood test may eventually reach the clinic, but it is not validated for diagnosis yet, so any result should be interpreted with a clinician. The same seed-detection idea now powers related tools, and researchers recently validated a p-tau217 blood test for Alzheimer’s risk.
Parkinson’s disease shares features with several other brain conditions. To see how the two most talked-about disorders differ, you can explore our dedicated Alzheimer’s disease guide, and when memory is affected early, you can also consult our dementia symptoms and types guide.
Glossarium
| Termijn | Definitie |
|---|---|
| Dopamine | A chemical messenger in the brain that helps make movements smooth and coordinated. |
| Substantia nigra | A small region deep in the brain where most dopamine-producing cells are located. |
| Alpha-synuclein | A protein that, in Parkinson’s disease, misfolds and clumps together inside nerve cells. |
| Lewy bodies | Abnormal deposits of alpha-synuclein found inside affected neurons. |
| Bradykinesia | Slowness of movement, one of the core features doctors look for. |
| Seed amplification assay | A specialized lab test that detects misfolded alpha-synuclein in spinal fluid or skin. |
| DaTscan | A brain imaging scan that shows dopamine activity and helps tell tremor types apart. |
| Parkinsonism | A broader term for Parkinson-like movement problems that can have several causes. |
| Ceruloplasmine | A copper-carrying protein measured to help rule out Wilson disease. |
Veelgestelde vragen
What is usually the first sign of Parkinson’s disease?
For many people the first noticeable sign is a slight tremor at rest, often in one hand or a few fingers. However, the very first changes are not always in movement. A reduced sense of smell, constipation, or acting out dreams during sleep can appear years earlier. Because these signs are common and have many causes, they are not proof of the disease on their own. What matters is the overall pattern, which a doctor can assess.
Is there a blood test that can detect Parkinson’s disease?
There is no routine blood test that confirms Parkinson’s disease today. Blood work is mainly used to rule out other conditions that can look similar, such as thyroid problems, vitamin B12 deficiency, or a copper disorder in younger patients. Specialized tests that detect misfolded alpha-synuclein exist, but they typically use spinal fluid or skin and are ordered by specialists. Blood-based markers are an active area of research and may reach the clinic in the future.
Kan de ziekte van Parkinson genezen worden?
There is no cure for Parkinson’s disease at present. However, treatment can control symptoms effectively, often for many years, and help people stay active and independent. Medications that restore or mimic dopamine, procedures such as deep brain stimulation, and supportive therapies like exercise and physical therapy all contribute. Research into treatments that could slow the disease is ongoing, and care continues to improve.
How is Parkinson’s disease different from Alzheimer’s disease?
Parkinson’s disease primarily affects movement, causing tremor, stiffness, and slowness, while Alzheimer’s disease primarily affects memory and thinking. The two conditions involve different brain regions and different proteins, although they can share some features, and cognitive changes can occur in later Parkinson’s. A doctor can distinguish between them through history, examination, and, when needed, imaging or other tests.
At what age does Parkinson’s disease usually start?
Parkinson’s disease most often begins after the age of 60, and the risk rises with age. A smaller number of people develop young-onset Parkinson’s before the age of 50, which sometimes has a stronger genetic component. Age alone does not cause the disease, and most older adults never develop it. Any new or persistent movement symptoms are worth discussing with a doctor regardless of age.
Does Parkinson’s disease run in families?
Most cases of Parkinson’s disease are sporadic, meaning they occur without a clear family pattern. A minority are linked to specific gene variants, such as LRRK2 and GBA, which can raise risk. Having a close relative with the disease slightly increases your own risk but is far from a guarantee. Genetic counseling and testing may be offered in cases of early onset or strong family history.
Bronnen
- National Institute of Neurological Disorders and Stroke — Parkinson’s Disease — ninds.nih.gov
- Mayo Clinic — Parkinson’s disease: Diagnosis and treatment, 2024 — mayoclinic.org
- Johns Hopkins Medicine — Parkinson’s Disease — hopkinsmedicine.org
- Siderowf A, et al. — Assessment of heterogeneity among participants in the Parkinson’s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study — Lancet Neurology, 2023 — doi.org/10.1016/S1474-4422(23)00109-6
- Simuni T, et al. — A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research — Lancet Neurology, 2024 — doi.org/10.1016/S1474-4422(23)00405-2
- Kim KY, et al. — Potential Exosome Biomarkers for Parkinson’s Disease Diagnosis: A Systematic Review and Meta-Analysis — International Journal of Molecular Sciences, 2024 — doi.org/10.3390/ijms25105307
- Gan YH, et al. — Large-scale proteomic analyses of incident Parkinson’s disease reveal new pathophysiological insights and potential biomarkers — Nature Aging, 2025 — doi.org/10.1038/s43587-025-00818-0
- de Bie RMA, et al. — Update on Treatments for Parkinson’s Disease Motor Fluctuations: An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review — Movement Disorders, 2025 — doi.org/10.1002/mds.30162
Verder lezen
- Volledig bloedbeeld (CBC): Hoe lees je je resultaten?
- Uitgebreid metabolisch panel (CMP): Hoe u uw resultaten moet interpreteren
- Liver Function Tests: How to Read Your Liver Panel
- Hypothyroidism: Symptoms, Diagnosis, and Treatments
- Beroerte (cerebrovasculair accident): Inzicht en handelen
Begrijp uw laboratoriumresultaten met AI DiagMe.
Parkinson’s disease cannot be confirmed by a single blood test, but lab work still matters, because it helps rule out conditions that can look similar. Tests such as thyroid-stimulating hormone (TSH), vitamin B12, and copper or ceruloplasmin are often part of that workup, and their reports can be hard to interpret on your own. AI DiagMe helps you understand what your results mean in clear language; it does not diagnose disease and does not replace your doctor.
Ontvang binnen enkele minuten een interpretatie van uw resultaten.
